Tony Ho
Senior Science Partner at Pivotal Life Sciences
About
Tony Ho, unusually academically accomplished, discovered acute motor axonal neuropathy, has 80+ publications, led first‑in‑class CRISPR therapies into clinical trials, and oversaw AstraZeneca Phase 3 programs driving Lynparza and Imfinzi.
Invests in
BiotechHealthtechMedical Devices